Topiramate

New Migraine Indication for Qudexy XR

New Migraine Indication for Qudexy XR

By

FDA grants 2 supplemental New Drug Applications for Qudexy XR capsules for use as prophylaxis of migraine headache.

Results From the CHAMP Trial for Pediatric Migraine

Results From the CHAMP Trial for Pediatric Migraine

By

Ultimately, the trial was stopped early for futility, as an interim analysis suggested that there would be no significant difference in benefit for the preventive medications vs placebo on migraine headache frequency.

Sign Up for Free e-Newsletters